References
- Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews 1991; 43: 109–142
- Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB Journal 1992; 6: 3051–3064
- Nussler A.K., Di Silvio M., Billiar T.R., Hoffman R.A., Geller D.A., Selby R., Madariaga J., Simmons R.L. Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. Journal of Experimental Medicine 1992; 176: 261–264
- Geller D.A., Nussler A.K., Di Silvio M., Lowenstein C.J., Shapiro R.A., Wang S.C., Simmons R.L., Billiar T.R. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proceedings of the National Academy of Sciences of the United States of America 1993; 90: 522–526
- Sonawane B.R., Yaffe S.J., Witmer C.M. Effects of endotoxin upon rat hepatic microsomal drug metabolism in vivo and in vitro. Xenobiotica 1982; 12: 303–313
- Renton K.W. Relationships between the enzymes of detoxication and host defense mechanisms. Biological Basis of Detoxication, J. Caldwell, W.B. Jakoby. Academic Press, New York 1983; 307–324, In
- Stadler J., Trockfeld J., Schmalix W.A., Brill T., Siewert J.R., Greim H., Doehmer J. Inhibition of cytochromes P4501A by nitric oxide. Proceedings of the National Academy of Sciences of the United States of America 1994; 91: 3559–3563
- Donato M.T., Guillén M.I., Jover R., Castell J.V., Gómez-Lechón M.J. Nitric oxide-mediated inhibition of cytochrome P450 by interferon-γ in human hepatocytes. Journal of Pharmacology and Experimental Therapeutics 1997; 281: 484–490
- Khatsenko O.G., Gross S.S., Rifkind A.B., Vane J.R. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proceedings of the National Academy of Sciences of the United States of America 1993; 90: 11 147–11 151
- Khatsenko O.G., Boobis A.R., Gross S.S. Evidence for nitric oxide participation in down-regulation of CYP2B1/2 gene expression at the pretranslational level. Toxicology Letters 1997; 90: 207–216
- Carlson T.J., Billings R.E. Role of nitric oxide in the cytokine-mediated regulation of cytochrome P-450. Molecular Pharmacology 1996; 49: 796–801
- Minamiyama Y., Takemura S., Imaoka S., Funae Y., Tanimoto Y., Inoue M. Irreversible inhibition of cytochrome P450 by nitric oxide. Journal of Pharmacology and Experimental Therapeutics 1997; 283: 1479–1485
- Pichard L., Fabre I., Fabre G., Domergue J., Saint Aubert B., Mourad G., Maurel P. Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. 1990
- Drug Metabolism and Disposition, 18: 595–606
- Schmiedlin-Ren P., Thummel K.E., Fisher J.M., Paine M.F., Lown K.S., Watkins P.B. Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1α,25-dihydroxyvitamin D3. 1997
- Molecular Pharmacology, 51: 741–754
- Paine M.F., Khalighi M., Fisher J.M., Shen D.D., Kunze K.L., Marsh C.L., Perkins J.D., Thummel K.E. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. Journal of Pharmacology and Experimental Therapeutics 1997; 283: 1552–1562
- Paine M.F., Shen D.D., Kunze K.L., Perkins J.D., Marsh C.L., McVicar J.P., Barr D.M., Gillies B.S., Thummel K.E. First-pass metabolism of midazolam by the human intestine. Clinical Pharmacology and Therapeutics 1996; 60: 14–24
- Miller M.J.S., Sadowska-Krowicka H., Chotinaruemol S., Kakkis J.L., Clark D.A. Amelioration of chronic ileitis by nitric oxide synthase inhibition. Journal of Pharmacology and Experimental Therapeutics 1993; 264: 11–16
- Miller M.J., Zhang X.J., Sadowska-Krowicka H., Chotinaruemol S., McIntyre J.A., Clark D.A., Bustamante S.A. Nitric oxide release in response to gut injury. Scandinavian Journal of Gastroenterology 1993; 28: 149–154
- Schuetz E.G., Beck W.T., Schuetz J.D. Modulators and substrates of P-glycoprotein and cytochrome P450 3A coordinately up-regulate these proteins in human colon carcinoma cells. Molecular Pharmacology 1996; 49: 311–318
- Gomez D.Y., Wacher V.J., Tomlanovich S.J., Herbert M.F., Benet L.Z. The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine. Clinical Pharmacology and Therapeutics 1995; 58: 15–19
- Fromm M.F., Busse D., Kroemer H.K., Eichelbaum M. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin. Hepatology 1996; 24: 796–801